Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.

<h4>Objective</h4>Left ventricular (LV) remodeling following myocardial infarction (MI) is characterized by progressive alterations of structure and function, named LV remodeling. Although several risk factors such as infarct size have been identified, LV remodeling remains difficult to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Marie Fertin, Gilles Lemesle, Annie Turkieh, Olivia Beseme, Maggy Chwastyniak, Philippe Amouyel, Christophe Bauters, Florence Pinet
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/79a0c282bc78458bb8c1724d778bbc66
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:79a0c282bc78458bb8c1724d778bbc66
record_format dspace
spelling oai:doaj.org-article:79a0c282bc78458bb8c1724d778bbc662021-11-18T08:59:41ZSerum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.1932-620310.1371/journal.pone.0071280https://doaj.org/article/79a0c282bc78458bb8c1724d778bbc662013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23967183/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objective</h4>Left ventricular (LV) remodeling following myocardial infarction (MI) is characterized by progressive alterations of structure and function, named LV remodeling. Although several risk factors such as infarct size have been identified, LV remodeling remains difficult to predict in clinical practice. Changes within the extracellular matrix, involving matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), are an integral part of left ventricular (LV) remodeling after myocardial infarction (MI). We investigated the temporal profile of circulating MMPs and TIMPs and their relations with LV remodeling at 1 year and clinical outcome at 3 years in post-MI patients.<h4>Methods</h4>This prospective multicentre study included 246 patients with a first anterior MI. Serial echocardiographic studies were performed at hospital discharge, 3 months, and 1 year after MI, and analysed at a core laboratory. LV remodeling was defined as the percent change in LV end-diastolic volume (EDV) from baseline to 1 year. Serum samples were obtained at hospital discharge, 1, 3, and 12 months. Multiplex technology was used for analysis of MMP-1, -2, -3, -8, -9, -13, and TIMP-1, -2, -3, -4 serum levels.<h4>Results</h4>Baseline levels of MMP-8 and MMP-9 were positively associated with changes in LVEDV (P = 0.01 and 0.02, respectively). When adjusted for major baseline characteristics, MMP-8 levels remained an independent predictor LV remodeling (P = 0.025). By univariate analysis, there were positive relations between cardiovascular death or hospitalization for heart failure during the 3-year follow-up and the baseline levels of MMP-2 (P = 0.03), MMP-8 (P = 0.002), and MMP-9 (P = 0.03). By multivariate analysis, MMP-8 was the only MMP remaining significantly associated with clinical outcome (P = 0.02).<h4>Conclusion</h4>Baseline serum MMP-8 is a significant predictor of LV remodeling and cardiovascular outcome after MI and may help to improve risk stratification.Marie FertinGilles LemesleAnnie TurkiehOlivia BesemeMaggy ChwastyniakPhilippe AmouyelChristophe BautersFlorence PinetPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 8, p e71280 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Marie Fertin
Gilles Lemesle
Annie Turkieh
Olivia Beseme
Maggy Chwastyniak
Philippe Amouyel
Christophe Bauters
Florence Pinet
Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.
description <h4>Objective</h4>Left ventricular (LV) remodeling following myocardial infarction (MI) is characterized by progressive alterations of structure and function, named LV remodeling. Although several risk factors such as infarct size have been identified, LV remodeling remains difficult to predict in clinical practice. Changes within the extracellular matrix, involving matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs), are an integral part of left ventricular (LV) remodeling after myocardial infarction (MI). We investigated the temporal profile of circulating MMPs and TIMPs and their relations with LV remodeling at 1 year and clinical outcome at 3 years in post-MI patients.<h4>Methods</h4>This prospective multicentre study included 246 patients with a first anterior MI. Serial echocardiographic studies were performed at hospital discharge, 3 months, and 1 year after MI, and analysed at a core laboratory. LV remodeling was defined as the percent change in LV end-diastolic volume (EDV) from baseline to 1 year. Serum samples were obtained at hospital discharge, 1, 3, and 12 months. Multiplex technology was used for analysis of MMP-1, -2, -3, -8, -9, -13, and TIMP-1, -2, -3, -4 serum levels.<h4>Results</h4>Baseline levels of MMP-8 and MMP-9 were positively associated with changes in LVEDV (P = 0.01 and 0.02, respectively). When adjusted for major baseline characteristics, MMP-8 levels remained an independent predictor LV remodeling (P = 0.025). By univariate analysis, there were positive relations between cardiovascular death or hospitalization for heart failure during the 3-year follow-up and the baseline levels of MMP-2 (P = 0.03), MMP-8 (P = 0.002), and MMP-9 (P = 0.03). By multivariate analysis, MMP-8 was the only MMP remaining significantly associated with clinical outcome (P = 0.02).<h4>Conclusion</h4>Baseline serum MMP-8 is a significant predictor of LV remodeling and cardiovascular outcome after MI and may help to improve risk stratification.
format article
author Marie Fertin
Gilles Lemesle
Annie Turkieh
Olivia Beseme
Maggy Chwastyniak
Philippe Amouyel
Christophe Bauters
Florence Pinet
author_facet Marie Fertin
Gilles Lemesle
Annie Turkieh
Olivia Beseme
Maggy Chwastyniak
Philippe Amouyel
Christophe Bauters
Florence Pinet
author_sort Marie Fertin
title Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.
title_short Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.
title_full Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.
title_fullStr Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.
title_full_unstemmed Serum MMP-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.
title_sort serum mmp-8: a novel indicator of left ventricular remodeling and cardiac outcome in patients after acute myocardial infarction.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/79a0c282bc78458bb8c1724d778bbc66
work_keys_str_mv AT mariefertin serummmp8anovelindicatorofleftventricularremodelingandcardiacoutcomeinpatientsafteracutemyocardialinfarction
AT gilleslemesle serummmp8anovelindicatorofleftventricularremodelingandcardiacoutcomeinpatientsafteracutemyocardialinfarction
AT annieturkieh serummmp8anovelindicatorofleftventricularremodelingandcardiacoutcomeinpatientsafteracutemyocardialinfarction
AT oliviabeseme serummmp8anovelindicatorofleftventricularremodelingandcardiacoutcomeinpatientsafteracutemyocardialinfarction
AT maggychwastyniak serummmp8anovelindicatorofleftventricularremodelingandcardiacoutcomeinpatientsafteracutemyocardialinfarction
AT philippeamouyel serummmp8anovelindicatorofleftventricularremodelingandcardiacoutcomeinpatientsafteracutemyocardialinfarction
AT christophebauters serummmp8anovelindicatorofleftventricularremodelingandcardiacoutcomeinpatientsafteracutemyocardialinfarction
AT florencepinet serummmp8anovelindicatorofleftventricularremodelingandcardiacoutcomeinpatientsafteracutemyocardialinfarction
_version_ 1718421029871681536